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Improved Peak Capacity for Capillary Electrophoretic
Separations of Enzyme Inhibitors with Activity-Based Detection
Using Magnetic Bead Microreactors
Xiaoyan Yan and S. Douglass Gilman
Department of Chemistry, Louisiana State University, 232 Choppin Hall, Baton Rouge, LA 70803

Abstract
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A technique for separating and detecting enzyme inhibitors was developed using capillary
electrophoresis with an enzyme microreactor. The on-column enzyme microreactor was
constructed using NdFeB magnet(s) to immobilize alkaline phosphatase-coated superparamagnetic
beads (2.8 μm diameter) inside a capillary before the detection window. Enzyme inhibition assays
were performed by injecting a plug of inhibitor into a capillary filled with the substrate, AttoPhos.
Product generated in the enzyme microreactor was detected by laser-induced fluorescence.
Inhibitor zones electrophoresed through the capillary, passed through the enzyme microreactor,
and were observed as negative peaks due to decreased product formation. The goal of this study
was to improve peak capacities for inhibitor separations relative to previous work, which
combined continuous engagement electrophoretically mediated microanalysis (EMMA) and
transient engagement EMMA to study enzyme inhibition. The effects of electric field strength,
bead injection time and inhibitor concentrations on peak capacity and peak width were
investigated. Peak capacities were increased to ≥20 under optimal conditions of electric field
strength and bead injection time for inhibition assays with arsenate and theophylline. Five
reversible inhibitors of alkaline phosphatase (theophylline, vanadate, arsenate, L-tryptophan and
tungstate) were separated and detected to demonstrate the ability of this technique to analyze
complex inhibitor mixtures.

Keywords

NIH-PA Author Manuscript

Capillary electrophoresis; Electrophoretically mediated microanalysis; Enzyme inhibition;
Magnetic beads

1 Introduction
Because enzyme catalysis plays a central role in biological chemistry, enzymes are one of
the most important classes of drug targets, and enzyme inhibitors have been central to the
drug discovery and development process [1]. Rapid, inexpensive and information-rich
analytical techniques are needed for enzyme inhibitor screening [1]. When potential enzyme
inhibitors are part of a synthetic or natural mixture of compounds, it would be desirable to
use analysis methods that simultaneously separate compounds in the mixture and detect their
inhibition of a target enzyme.
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Capillary electrophoresis (CE) has been successfully applied for studies of enzyme kinetics
and enzyme inhibition [2,3]. The sample volume required for CE is extremely small (pLnL). Capillary electrophoresis is a powerful separation technique and is capable of
separating reaction products from substrates and enzymes with high efficiency.
Electrophoretically mediated microanalysis (EMMA) is a CE-based technique, which was
first described by Bao and Regnier in 1992 [4] and is commonly applied for performing
enzyme assays and studying enzyme inhibition [2,3,5]. In EMMA, an enzyme-catalyzed
reaction is carried out by mixing reaction components electrophoretically in a capillary
column. There are two formats of EMMA, continuous engagement EMMA and transient
engagement EMMA. In continuous engagement EMMA, enzyme assays are performed by
injecting a zone of enzyme into a capillary that has been filled with a solution containing the
substrate for the enzyme [5]. Product is formed as the enzyme migrates through the
capillary, and the product is detected as a plateau. In transient engagement EMMA, the
enzyme and the substrate are injected into the capillary as distinct zones [5]. Product is
formed when the enzyme and substrate zones mix electrophoretically in the capillary, and
the product is detected as a separate peak.
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Enzyme inhibition studies have been performed using EMMA in both capillaries and
microchips [3]. The first report using EMMA to study enzyme inhibition by Saevels et al.
investigated the inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)
adenine (EHNA) in a capillary using transient engagement EMMA [6]. The inhibitor,
EHNA, was added to the running buffer, the enzyme solution and the substrate solution. The
voltage was turned off when the zones of substrate and enzyme were overlapped to allow
more product to form for detection, and it was then reapplied to separate the zones of
enzyme, substrate, and product. Hadd et al. studied the inhibition of β-galactosidase by
phenylethyl β-D-thiogalactoside, p-hydroxymercuribenzoic acid and D-lactose in a
microchip device [7]. Substrate, enzyme and inhibitor were electrokinetically pumped from
separate reservoirs and were mixed at a four-way intersection to develop the enzymecatalyzed reaction at the downstream reaction channel. A method combining continuous
engagement EMMA and transient engagement EMMA was developed by Whisnant et al.
and used to study the inhibition of alkaline phosphatase in a capillary [8,9]. The capillary
was first filled with an electrophoresis buffer that included the substrate. The inhibitor and
enzyme were then injected electrokinetically into the capillary as separate zones. A product
plateau was formed as the enzyme zone migrated through the capillary and interacted
continuously with the substrate. The reaction product was fluorescent and detected by laserinduced fluorescence (LIF). A negative inhibition peak was created on the product plateau
when the enzyme and inhibitor zones mixed and then separated electrophoretically. Several
other groups have reported studies of enzyme inhibition based on variations of EMMA in
capillaries and microchips [3].
In 1999, Hadd et al. reported an EMMA-based method in a microchip device, which could
separate mixtures of inhibitors and detect them based on their inhibition of the target
enzyme [10]. A mixture of four inhibitors of acetylcholinesterase, tetramethylammonium
chloride, tetraethylammonium chloride, tacrine and edrophonium, was injected
electrokinetically through the first intersection on the microchip as a short zone into a
separation channel. Enzyme also flowed continuously through the first intersection into the
separation channel. The enzyme-catalyzed reaction was initiated after electrophoretic
separation of the inhibitors by using confluent mixing to add substrate at the second
intersection to the enzyme and inhibitor stream. A final fluorescent product was generated
from the enzyme-catalyzed reaction product by adding a derivatization reagent at the third
intersection. The four inhibitors of acetylcholinesterase were detected as negative peaks due
to reduced product formation. Despite the promise of this early study, no subsequent reports
have appeared in the literature applying this approach or further developing it. In principle,
Electrophoresis. Author manuscript; available in PMC 2011 January 1.
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the EMMA method for studying enzyme inhibition developed by Whisnant et al. [8,9] could
be used to separate mixtures of inhibitors and detect them based on their inhibition of the
target enzyme; however, poor peak capacity limits this approach in practice. For example,
the peak capacity based on studies of the reversible inhibition of alkaline phosphatase by
theophylline is calculated to be 3 [9].
The goal of this study was to develop a simple, on-column CE method in a capillary for
separating mixtures of inhibitors and detecting these molecules based on their inhibition of a
target enzyme. To overcome the limited peak capacity of the EMMA method developed by
Whisnant and coworkers [8,9], the enzyme was immobilized in the CE capillary before the
detector by immobilizing enzyme-coated paramagnetic beads with a magnetic field [11].
The enzyme inhibitors were separated by CE before reaching the enzyme microreactor. The
effects of several experimental variables on the assays, such as bead injection time and
separation potential, were investigated. Five reversible inhibitors of alkaline phosphatase
were separated, and their individual inhibition peaks were observed using this approach.
This method was directly compared to the EMMA method reported by Whisnant et al. [8,9]
using the same enzyme, substrate and mixture of inhibitors.

2 Materials and methods
2.1 Reagents
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Alkaline phosphatase (EC 3.1.3.1 from calf intestine) and AttoPhos (2′-[2-benzothiazoyl]-6′hydroxybenzothiazole phosphate) were obtained from Promega (Madison, WI). Sodium
phosphate and sodium hydroxide were purchased from Fisher Scientific (Fair Lawn, NJ).
Sodium vanadate was from Acros Organics (Pittsburgh, PA). Other chemicals were supplied
by Sigma-Aldrich (St. Louis, MO). All solutions were prepared in ultrapure water (> 18
MΩ·cm) from a Modulab water purification system (United States Filter Corp.; Palm Desert,
CA).
2.2 CE-LIF instrumentation
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The CE-LIF instrument was constructed in house and is similar to previous instruments
[8,9]. A schematic representation of the instrument is presented in Figure S1. The LIF
detector is not shown in detail. The 457.9-nm line of an air-cooled argon ion laser (543RAP-A01, Melles Griot; Carlsbad, CA) was used for excitation. The laser beam was focused
onto the capillary by a CaF2 plano convex lens (f = 20.0 mm) (Thorlabs; Newton, NJ). The
laser power at the capillary was 24.0 mW. The fluorescence was collected at 90° relative to
the excitation beam by a 20× microscope objective (0.5 NA; Melles Griot; Carlsbad, CA),
and was filtered by a 560 ± 10 nm bandpass filter (53900, Oriel; Stratford, CT) and an 800
μm diameter pinhole (Oriel). The fluorescence was then detected by a PMT (HC120-01,
Hamamatsu; Bridgewater, NJ) at a potential of 1000 V. The PMT output was filtered by a
low-pass filter at 50 Hz, and the data were collected at 20 Hz by the data acquisition board
(PCI-6229, National Instruments; Austin, TX). A LabVIEW program (Version 7.1, National
Instruments) was written and used for data acquisition. The data were analyzed using
OriginLab 7.5 (Northampton, MA).
A Spellman CZE1000R high-voltage power supply (Hauppauge, NY) was used to apply the
electrophoretic potential. Fused-silica capillaries with a 50 μm i.d. and 220 μm o.d. from
SGE (Austin, TX) were used. For all experiments, the capillaries were 60.0 cm total length
and 45.0 cm to the detection window. The detection window was made by removing the
polyimide coating using a window maker (MicroSolv Technology; Eatontown, NJ). Each
new capillary was rinsed before use with 0.1 M NaOH, water, and then diethanolamine
(DEA) buffer (50.00 mM, pH 9.50) using a manual syringe pump for 10 min, respectively.

Electrophoresis. Author manuscript; available in PMC 2011 January 1.
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All solutions used for CE were filtered through a 0.2-μm membrane filter (Whatman;
Hillsboro, OR).
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2.3 Enzyme immobilization on magnetic beads

NIH-PA Author Manuscript

Superparamagnetic polystyrene beads (Dynabeads M-270 Epoxy) with a diameter of 2.8 μm
were purchased from Invitrogen Dynal (Oslo, Norway). The covalent attachment of alkaline
phosphatase to the magnetic beads was performed using the protocol provided by the
manufacturer. Briefly, a batch of magnetic beads (1.5 mg, 1.0×108 beads) was washed twice
with 100 μL of 100.0 mM sodium phosphate buffer at pH 7.40. In each washing step, the
beads were separated from the wash buffer by fixing the bead suspension with a NdFeB
magnet and removing the supernatant. The washed beads were then resuspended in 30 μL of
the sodium phosphate buffer (3.3 × 109 beads/mL). After mixing the 30-μL suspension of
washed beads and 30 μL of 14 μM alkaline phosphatase in the same phosphate buffer, 30 μL
of 3.000 M ammonium sulfate in the pH 7.40 phosphate buffer was added to enhance
binding of alkaline phosphatase to the beads. The resultant mixture was incubated with slow
tilt rotation on a rocking platform for 24 h at room temperature. After incubation, the beads
were washed four times with 150 μL aliquots of DEA buffer (50.00 mM, pH 9.50) to
remove alkaline phosphatase molecules that were not covalently attached to the beads.
Finally, the beads were resuspended in 200 μL DEA buffer (5.0 × 108 beads/mL) and stored
in the refrigerator at 4 °C until use. The coated bead suspensions were diluted to 1.7 × 108
beads/mL, and the suspension was homogenized with a vortex mixer before injection into
the CE capillary. Different injections from the same batch of beads were used for all of the
experiments reported in this paper.
2.4 Magnetic bead immobilization in the capillary
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A copper holder was constructed to hold the magnets that fixed the magnetic beads inside
the capillary and to control the temperature in this region of the capillary. This holder is
illustrated in Fig. S1. The holder positioned the magnet(s) near the capillary surface, 27.0
cm from injection end of the capillary. Water from a thermostatted bath was circulated
through the copper holder to control the temperature of a 5.0-cm section of the capillary,
centered at the magnet. Permanent NdFeB magnets (B442 and D24) used in this work were
purchased from K&J Magnetics (Jamison, PA). A B442 magnet (3700 Gauss) was secured
in the holder with one pole perpendicular to the capillary bore. The distance from the center
of the capillary bore to the face of the magnet closest to the capillary was 350 μm. In a 2magnet configuration, a pair of D24 magnets (3895 Gauss) was secured in the holder. The
two magnets were arranged at ±20° relative to the longitudinal axis of the capillary bore
with their north poles facing the capillary bore [12]. The distance from the inner edge of
each magnet to the center of the capillary bore was 395 μm. To create an enzyme
microreactor with magnetic beads, the beads coated with alkaline phosphatase were
electrokinetically injected into the capillary at 300 V/cm and then transported to the
immobilization zone by electrophoresis (200 V/cm) in DEA buffer (50.00 mM, pH 9.50).
After a series of experiments, the beads could be easily removed by rinsing the capillary
with DEA buffer using a manual syringe pump.
An inverted microscope (Nikon ECLIPSE TE 300) was used with a 10× objective to image
fixed magnetic beads inside the capillary. Images for the 1-magnet configuration were
captured by a CCD camera and imaging software (WinView Software Version 32) from
Princeton Instruments (Trenton, NJ). A digital camera (Sony DSC-W55/P; Sony Electronics,
Inc.) was used with the 2-magnet configuration to record images of bead plugs observed
through the eyepiece diopter of the microscope. The bead plug lengths were measured using
the inner diameter of the capillary (50 μm) as a reference.
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For heterogeneous enzyme assays in a capillary with fixed magnetic beads, the running
buffer was 0.100 mM AttoPhos in 50.00 mM DEA at pH 9.50. AttoPhos is a fluorogenic
substrate for alkaline phosphatase. All inhibitor solutions were prepared in the running
buffer. Inhibitors were electrokinetically injected at 200 V/cm for 3.0 s. The applied electric
field for carrying out the enzyme assays was 200 V/cm unless otherwise noted. The
electrode and the capillary inlet were dipped in DEA buffer before and after each injection
of inhibitor to prevent cross contamination of the running buffer and inhibitor solution. The
capillary was thermostatted at 25.0 °C. For heterogeneous enzyme inhibition assays, peak
capacity (nc) was calculated using Equation 1:

(1)

where t is the migration time of an inhibitor, and w1/2 is the full width at half maximum of
an inhibition peak [13].
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For homogeneous CE enzyme inhibition assays, the basic experimental procedures were the
same as those described previously [9]. The capillary was filled with the same running
buffer used for the heterogeneous enzyme inhibition assays, including substrate. A zone of
an alkaline phosphatase inhibitor, theophylline, was first injected for 3.0 s at 12.0 kV into
the capillary. A potential of 12.0 kV was then applied for 30.0 s (40.0 s when a mixture of
inhibitors was injected). Next, a plug of 51 pM alkaline phosphatase was injected for 3.0 s at
12.0 kV. Finally, a separation potential of 12.0 kV (200 V/cm) was applied. The enzyme
concentration used for homogeneous assays was selected so that the activity of the enzyme
zone was approximately the same as that for a plug of magnetic beads with immobilized
enzyme. Zones of enzyme in solution or beads with immobilized enzyme were injected with
AttoPhos in DEA buffer, and the resulting fluorescent product signals were compared. The
inhibitor solutions contained the inhibitor as well as 0.100 mM AttoPhos in 50.00 mM DEA
at pH 9.50. The electrode and the capillary inlet were dipped in DEA buffer before and after
each injection to prevent cross contamination of the running buffer, enzyme solution and
inhibitor solution. The thermostatting system for the homogeneous assays was constructed
as described previously [9]. To thermostat the capillary, Teflon tubing was used to enclose
the capillary from the injection end to the detection window, and N2 (25.0 °C, 8 psi) flowed
through the Teflon tubing around the capillary. The temperature of the N2 was controlled by
passing it through a coil of tubing in a temperature-controlled water bath before it passed
over the capillary to control the capillary temperature.

NIH-PA Author Manuscript

3 Results and discussion
3.1 Enzyme microreactors for enzyme inhibition assays
The goal for this work was to expand the ability of CE enzyme inhibition assays to separate
and detect mixtures of inhibitors by increasing the peak capacity compared to our previous
work [8,9]. The approach presented here is to immobilize the enzyme of interest inside the
capillary before the detector. The running buffer contained a fluorogenic substrate for the
target enzyme. In this work, the fluorogenic substrate was AttoPhos, and the enzyme studied
was alkaline phosphatase. Inhibitor mixtures will separate by CE before reaching the
enzyme microreactor, and each inhibitor zone will produce a negative inhibition peak
(reduced fluorescent product formation) as it migrates through the enzyme microreactor and
inhibits the enzyme. Chetwyn and Susan Lunte used a related approach to separate and
detect mixtures of acetylcholinesterase inhibitors based on an enzyme-modified electrode
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placed at the end of a CE capillary [14]. In the work presented here, the fluorescent reaction
product is detected by LIF downstream from the enzyme microreactor.
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The enzyme microreactors were constructed using rare earth magnets to fix enzyme-coated
magnetic beads inside the capillary before the detection window [11]. Two different magnet
configurations were used in this work, and for both configurations the magnets were placed
at the same distance from the injection end of the capillary. In the 1-magnet configuration, a
single magnet was placed with its pole facing the capillary bore. In the 2-magnet
configuration, two identical magnets were positioned at ±20° relative to the long axis of the
capillary with their north poles facing the capillary [12]. In both configurations, the magnets
were able to hold magnetic beads in place inside capillary at the electrophoretic field
strengths used in this study.

NIH-PA Author Manuscript

The use of magnetic immobilization of enzyme-labeled beads greatly simplified the
development and optimization of this approach to CE-based enzyme inhibition assays.
Enzyme microreactors could be constructed simply by electrokinetically injecting enzymecoated magnetic beads into a capillary and then transporting the beads to the immobilizing
magnet by electrophoresis in DEA buffer. No modification of the inner capillary surface was
required. A single injection of beads was routinely used for multiple injections throughout
the day with no apparent loss of enzyme activity. Although no attempt was made to
determine the maximum number of consecutive experiments that could be performed from a
single bead plug (1 bead injection), up to 19 consecutive experiments were performed for
this work using a single bead plug, and more than 10 consecutive experiments were
performed routinely using a single bead plug. A new microreactor could be created at any
time by injection of a new bead plug from the same batch of enzyme-coated beads.
3.2 Optimization of the enzyme assay
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The temperature at the enzyme microreactor and the concentration of substrate in the
running buffer were optimized before beginning enzyme inhibition studies. The pH value
used for these studies (pH 9.50), was based on optimization for a previous study using
EMMA with alkaline phosphatase [8]. This pH value also falls within the pH range listed by
the manufacturer for this alkaline phosphatase substrate (pH 9.0–10.3). A 5.0 cm section of
the capillary centered at the magnet was temperature controlled by circulating water from a
thermostatted bath through the copper holder. The enzyme activity was nearly constant from
25–45 °C, using the 1-magnet configuration for immobilizing alkaline phosphatase-coated
magnetic beads (Fig. S2). A temperature of 25 °C was used for subsequent experiments.
Although the temperature of the capillary was controlled externally at 25 °C, it is important
to note that the temperature in the bore of the capillary will be higher than this due to Joule
heating [15]. The electrophoretic current for this experiment was 3.9 μA.
The substrate concentration was optimized by measuring the fluorescence signal when
buffers with AttoPhos concentrations ranging from 0.005 to 0.500 mM were allowed to
electrophorese through the capillary at 200 V/cm. The fluorescence signal due to product
formation at each AttoPhos concentration was recorded when it became stable. The value of
Km was determined to be 0.026 mM by fitting the experimental data in the resulting plot of
fluorescence vs. substrate concentration (Figure S3) nonlinearly to the Michaelis–Menten
equation. An AttoPhos concentration of 0.100 mM was used for subsequent experiments.
3.3 Inhibition assays
An electropherogram of an enzyme inhibition assay for sodium arsenate, a reversible
competitive inhibitor of alkaline phosphatase, [16] is presented in Fig. 1. The enzyme
microreactor was constructed using a single magnet. The capillary first was filled with a
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0.100 mM AttoPhos solution to obtain a constant fluorescence signal from the enzymecatalyzed reaction product (Fig. S4). Then, 0.125 mM sodium arsenate was injected for 3.0 s
at 12.0 kV. Finally, a separation potential of 12.0 kV was applied. At 11.2 min, a decrease in
product formation was observed due to the inhibitor zone passing through the plug of
enzyme-coated magnetic particles. After the inhibitor zone migrated past the plug of beads,
the product fluorescence returned to its original level, and the enzyme activity was restored,
demonstrating that sodium arsenate is a reversible inhibitor of alkaline phosphatase.
The electropherogram also contains several artifact peaks. The two unresolved peaks at ~2.3
min resulted from product formation during zero-potential incubation, which occurred
during injection. The first peak near 2.3 min was generated when the high voltage was
turned off just before the inhibitor was injected. The second peak was generated when the
high voltage was turned off just after the inhibitor injection and before application of the
separation potential. There are also two reproducible artifact peaks (a positive peak and a
negative peak) at ~4.9 min, and the cause of these two peaks is unclear. Electropherograms
for the same experiments carried out in an enzyme microreactor constructed with two
magnets (Fig. S5) are similar in appearance to those obtained using a single magnet.
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The inhibition of alkaline phosphatase by theophylline was also studied with both enzyme
microreactors. Theophylline is a reversible, noncompetitive inhibitor of alkaline phosphatase
[17]. An electropherogram for a 3.0-s injection of 1.00 mM theophylline is shown in Fig. 2.
The negative peak at 8.4 min is due to theophylline inhibition. The artifact peaks are almost
identical to those observed for arsenate.
3.4 Effects of electric field strength and bead injection time on peak capacity
The effects of the electric field strength and bead injection time on the peak capacity (nc) for
separation of reversible inhibitors were investigated to optimize the ability of the enzyme
inhibition assays to resolve mixtures of inhibitors. Inhibition assays of alkaline phosphatase
by arsenate were performed at different electric field strengths using 1 and 2-magnet enzyme
microreactors. A plot of the peak capacity vs. field strength is presented in Fig. 3. For both
types of enzyme microreactors, the peak capacity decreased with increased electric field
strength. Taking into consideration both the peak capacity and the total analysis time, an
electric field strength of 200 V/cm was chosen for later experiments (nc ≈ 20).
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The results of inhibition assays (arsenate, alkaline phosphatase) with different bead injection
times using both microreactor configurations are presented in Fig. 4. Increasing the bead
injection time increased the total number of beads injected and the bead plug length (Fig.
S6). The image of a bead plug for an injection time of 15 s for the 2-magnet configuration is
shown in Fig. S6. The density and total number of magnetic beads in a plug cannot be
readily determined from 2-dimensional images of the 3-dimensional bead plug.
Figure 4 shows a plot of peak capacity as the bead injection time was increased from 3.0 s to
90 s. For both magnet configurations, the peak capacity decreased sharply when the bead
injection time was increased from 15 to 30 s. There appears to be a slight increasing trend in
peak capacity as the injection time was increased from 30 to 90 s. For inhibition assays by
arsenate, the migration time of the inhibitor did not change much as the bead injection time
was increased, and the changes in peak capacity vs. bead injection time resulted mainly from
variation of the inhibition peak width. The inhibition peak width for inhibition assays using
enzyme microreactors with magnetic beads is a complex and interesting phenomenon. The
inhibition peak width ultimately reflects the decrease in production of enzyme-catalyzed
reaction product over time and does not necessarily represent the physical width of the
inhibitor zone. In this study, our goal was to improve the peak capacity for inhibitor
separations, so we focused on the peak capacity for optimizing these assays.
Electrophoresis. Author manuscript; available in PMC 2011 January 1.
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The increase in bead injection time also affected the S/N for the inhibition peaks for both
enzyme microreactor types (Figure S7a). The fluorescence signal due to enzyme-catalyzed
product formation increased as the number of beads immobilized increased due to increased
bead injection time. With longer magnetic bead injection time, the inhibition peak height
increased; however, the baseline noise also increased. The S/N of the inhibition peak only
changed slightly for the bead injection times investigated here. A magnetic bead injection
time of 15.0 s was used for later experiments to obtain an enhanced peak capacity (nc ≈ 20)
and S/N.
Inhibition of alkaline phosphatase by theophylline with different magnetic bead injection
times also was studied for both magnet configurations. These results are shown in Fig. S7 (b
and c). The peak capacity for theophylline was less impacted by the bead injection time
compared to arsenate, ranging only from 17–25 for all bead injection times and both enzyme
microreactor configurations. The S/N increased for theophylline by approximately a factor
of two for both magnet configurations when the bead injection time was increased from 3.0
to 15 s. At longer bead injection times, the S/N ratio was relatively stable as was observed
for arsenate inhibition.
3.5 Inhibition peak shape and inhibitor concentration
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To investigate the effect of inhibitor concentration on inhibition peak shape, different
concentrations of sodium arsenate were injected for 3.0 s using both 1 and 2-magnet enzyme
microreactors. Figure 5 shows electropherograms for inhibition assays at different arsenate
concentrations using a 1-magnet enzyme microreactor. The electropherograms are
artificially offset vertically to more clearly show the inhibition peaks, but the fluorescence
baselines were the same in the original electropherograms. The inhibition peaks became
deeper and broader as the inhibitor concentration increased. Plots of the inhibition peak
width at half maximum (w1/2) vs. the inhibitor concentration (Fig. 6) for both enzyme
microreactor types show that the peak widths increased by more than a factor of 20 in both
cases. The positive peaks at ~8.9 min are fluorescein, which was used as a control since it is
not expected to interact with the immobilized enzyme and magnetic beads. The fluorescein
peak widths were constant at ~0.04 min at inhibitor concentrations from 0.0125 mM to 1.25
mM, and decreased to 0.01 min at an inhibitor concentration of 12.5 mM. These relatively
sharp fluorescein peaks indicate that physical obstruction of the capillary by the bead plug is
not contributing significantly to the band broadening observed for the inhibition peaks. The
broadening of the inhibition peaks likely results from interaction between inhibitor and
enzyme when the inhibitor migrates through the bead plug. The artifact peaks at ~5.0 min
were similar for the assays at lower arsenate concentrations, but became deeper and wider at
arsenate concentration of 12.5 mM. Presumably the changes to the fluorescein peak and the
artifact peaks for the 12.5 mM arsenate sample were caused by the increased ionic strength
of the sample due to arsenate.
The effect of inhibitor concentration on inhibition peak shape was also studied for
theophylline using both enzyme microreactors. The electropherograms for these experiments
with a 1-magnet microreactor are presented in Fig. S8. Theophylline inhibition was also
studied using the EMMA method previously reported by Whisnant et al. [8,9]. The
electropherograms for the EMMA studies are presented in Fig. S9. Figure 7 shows plots of
the inhibition peak widths at half maximum (w1/2) vs. theophylline concentration for all
three assays. For all three assays the peak width increases by a factor of 6 as the
theophylline concentration increases from 0.500 to 10.0 mM. At all inhibitor concentrations,
the inhibition peak width for heterogeneous assays is larger than that for the homogeneous
assay (1.5–2×). These results are consistent with the hypothesis that the immobilization of
the enzyme on magnetic beads is not contributing significantly to the band broadening
observed here. Because the inhibitor is present at such high concentrations relative to the
Electrophoresis. Author manuscript; available in PMC 2011 January 1.
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enzyme in both heterogeneous and homogeneous assays, it is unlikely that the overall
inhibitor zone is physically broadened by interaction with the enzyme. The exact nature of
the broadening of the inhibition peaks and its dependence on inhibitor concentration remains
unclear. It is important to note that separation efficiency and peak capacity values are
compromised when the inhibitor concentration is high.
3.6 Separation and detection of enzyme inhibitor mixtures
Figure 8 presents a separation of a mixture of 5 inhibitors of alkaline phosphatase using a 1magnet enzyme microreactor. The inhibitors were electrophoretically separated in the
capillary before reaching the enzyme microreactor, and the inhibitor zones produced
negative peaks due to reduced product formation as they passed through the enzyme
microreactor. All 5 analytes, tryptophan, theophylline, vanadate, arsenate and tungstate, are
reversible inhibitors of alkaline phosphatase [16–19]. The same experiment was performed
with a 2-magnet enzyme microreactor (Fig. S10). All 5 inhibitors as well as fluorescein
(peak 6) were resolved from each other and from artifact peaks in both experiments.
Inhibition assays of the five species also were carried out individually so that the inhibition
peaks could be identified according to their migration times (data not shown).
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The same separation was attempted using the homogeneous method combining continuous
EMMA and transient engagement EMMA [8,9]. An electropherogram for this experiment is
presented in Fig. 9. Only two peaks are apparent in the product plateau in the
electropherogram from 6.2 to 7.0 min. Based on the migration order of the inhibitors from
the experiments in Figs. 8 and S10 as well as experiments using the homogeneous EMMA
method in which the samples were spiked with arsenate or tryptophan, these peaks were
identified as theophylline (6.5 min) and vanadate (6.8 min). Tryptophan migrated fastest
among the five inhibitors, and the enzyme zone probably did not overtake the tryptophan
zone before it reached the LIF detector. Arsenate and tungstate have the slowest migration
times and were overtaken first by the enzyme zone. This will result in inhibition of the
enzyme, but the inhibitors were probably unresolved, and the inhibition was observed at the
far edge of the plateau (~6.9 min). This will not produce distinct inhibition peaks, but will
make the product plateau appear narrower. These results show that the homogeneous
EMMA method has very limited peak capacity due to the constraints of the reaction product
plateau width, and in this case it cannot separate and detect all five inhibitors of alkaline
phosphatase.

4 Concluding Remarks
NIH-PA Author Manuscript

A simple CE method has been developed that is capable of separating mixtures of enzyme
inhibitors and detecting the inhibitors based on their inhibition of a target enzyme using an
on-column enzyme microreactor. This approach resulted in greatly increased peak capacity
(nc ≈ 20) compared to previous work, which combined continuous engagement EMMA and
transient engagement EMMA for enzyme inhibition studies [8,9]. This new method was able
to resolve a mixture of 5 inhibitors of alkaline phosphatase, while the same sample only
produced 2 distinct inhibition peaks using the previous method. The enzyme microreactor
was created by electrophoretically loading magnetic beads coated with the target enzyme
into a capillary and fixing the beads in the capillary using inexpensive rare earth magnets.
This approach avoids the complications of carrying out reactions inside the capillary to
immobilize the enzyme. The immobilized enzyme can be replaced by simply rinsing the
capillary at high pressure and injecting a new batch of enzyme-coated magnetic beads.
Enzyme microreactors based on one magnet and two magnets were used in this work. There
was no significant advantage obtained using the more complicated 2-magnet microreactor.
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Figure 1.

Electropherogram of an enzyme inhibition assay (inhibition of alkaline phosphatase by
arsenate) using a 1-magnet enzyme microreactor. A single B442 magnet (3700 Gauss) was
used to immobilize magnetic beads inside the capillary. Magnetic beads (1.7 × 108 beads/
mL) coated with alkaline phosphatase in DEA buffer (50.00 mM, pH 9.50) were injected for
30.0 s at 18.0 kV (300 V/cm). Next, a potential of 12.0 kV (200 V/cm) was applied to the
capillary filled with DEA buffer to transport the beads to the immobilizing magnet. The
running buffer (50.00 mM DEA, pH 9.50) contained 0.100 mM AttoPhos. The inhibitor,
0.125 mM sodium arsenate, was injected for 3.0 s at 12.0 kV. Finally, a separation potential
of 12.0 kV was applied.
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Figure 2.

Electropherogram of an enzyme inhibition assay (inhibition of alkaline phosphatase by
theophylline) using an enzyme microreactor constructed with a single magnet. The inhibitor,
1.00 mM theophylline, was injected for 3.0 s at 12.0 kV, and then the separation potential of
12.0 kV was applied. Magnetic beads (1.7 × 108 beads/mL) were injected for 15.0 s at 18.0
kV. All other experimental conditions are the same as in Fig. 1.
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Figure 3.

Effect of electric field strength on peak capacity (nc) for assays of alkaline phosphatase
inhibition by arsenate. Experimental conditions are the same as in Fig. 1, except that the
electric field strength was varied as indicated. The electric field strength for each arsenate
injection matched the separation field strength for that experiment.
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Figure 4.

Effect of bead injection time on peak capacity (nc) for assays of alkaline phosphatase
inhibition by arsenate. Experimental conditions are the same as in Fig. 1, except that the
bead injection time was varied as indicated.
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Figure 5.

Electropherograms of enzyme inhibition assays at different arsenate concentrations using a
1-magnet enzyme microreactor. Magnetic beads (1.7 × 108 beads/mL) were injected for 15.0
s at 18.0 kV. A mixture of 0.5 μM fluorescein and the inhibitor, arsenate, was injected for
3.0 s at 12.0 kV, and then the separation potential of 12.0 kV was applied. All other
experimental conditions are the same as in Fig. 1. The electropherograms were artificially
offset along the vertical axis so the inhibition peaks could be viewed without overlap.
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Figure 6.

Plots of inhibition peak width at half maximum (w1/2) vs. inhibitor concentration for assays
of alkaline phosphatase inhibition by arsenate. Experimental conditions are the same as in
Fig. 1, except that magnetic beads (1.7 × 108 beads/mL) were injected for 15.0 s at 18.0 kV.
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Figure 7.

Plot of inhibition peak width at half maximum (w1/2) vs. inhibitor concentration for assays
of alkaline phosphatase inhibition by theophylline. Experimental conditions for
heterogeneous assays using enzyme microreactors are the same as in Fig. 1, except that
magnetic beads (1.7 × 108 beads/mL) were injected for 15.0 s at 18.0 kV. For homogeneous
assays based on EMMA, a zone of theophylline (0.500, 1.00, 5.00 and 10.0 mM) was
injected for 3.0 s at 12.0 kV into a capillary filled with 0.100 mM AttoPhos in 50.00 mM
DEA at pH 9.50. Next, a potential of 12.0 kV was applied for 30.0 s. Then, a plug of 51 pM
alkaline phosphatase was injected into the capillary for 3.0 s at 12.0 kV. Finally, a separation
potential of 12.0 kV was applied.
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Figure 8.

Separation of alkaline phosphatase inhibitors using a 1-magnet enzyme microreactor. Peak
identities are: 1. tryptophan; 2. theophylline; 3. sodium vanadate; 4. sodium arsenate; 5.
sodium tungstate; 6. fluorescein. Magnetic beads (1.7 × 108 beads/mL) were injected for
15.0 s at 18.0 kV. A mixture of five inhibitors was injected for 3.0 s at 12.0 kV. Other
experimental conditions are the same as in Fig. 1.
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Figure 9.

Separation of alkaline phosphatase inhibitors using homogeneous EMMA. Peak identities
are: 1. theophylline; 2. sodium vanadate. A mixture of five alkaline phosphatase inhibitors
was injected for 3.0 s at 12.0 kV into a capillary filled with 0.100 mM AttoPhos (50.00 mM
DEA, pH 9.50). Next, a potential of 12.0 kV was applied for 40.0 s. Then, a plug of 51.0 pM
alkaline phosphatase was injected into the capillary for 3.0 s at 12.0 kV. Finally, a separation
potential of 12.0 kV was applied.
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